|
1
|
Jendle J, Nauck MA, Matthews DR, Frid A,
Hermansen K, Düring M, Zdravkovic M, Strauss BJ and Garber AJ;
LEAD-2 and LEAD-3 Study Groups: Weight loss with liraglutide, a
once-daily human glucagon-like peptide-1 analogue for type 2
diabetes treatment as monotherapy or added to metformin, is
primarily as a result of a reduction in fat tissue. Diabetes Obes
Metab. 11:1163–1172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao X, Liu G, Shen H, Gao B, Li X, Fu J,
Zhou J and Ji Q: Liraglutide inhibits autophagy and apoptosis
induced by high glucose through GLP-1R in renal tubular epithelial
cells. Int J Mol Med. 35:684–692. 2015.PubMed/NCBI
|
|
3
|
Shyangdan D, Cummins E, Royle P and Waugh
N: Liraglutide for the treatment of type 2 diabetes. Health Technol
Assess. 15(Suppl 1): S77–S86. 2011. View Article : Google Scholar
|
|
4
|
Gough SC: Liraglutide: From clinical
trials to clinical practice. Diabetes Obes Metab. 14(Suppl 2):
S33–S40. 2012. View Article : Google Scholar
|
|
5
|
Lind T, Sundqvist A, Hu L, Pejler G,
Andersson G, Jacobson A and Melhus H: Vitamin a is a negative
regulator of osteoblast mineralization. PLoS One. 8:e823882013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kanazawa I, Yamaguchi T, Yano S, Yamauchi
M, Yamamoto M and Sugimoto T: Adiponectin and AMP kinase activator
stimulate proliferation, differentiation, and mineralization of
osteoblastic MC3T3-E1 cells. BMC Cell Biol. 8:512007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhong X, Xiu LL, Wei GH, Liu YY, Su L, Cao
XP, Li YB and Xiao HP: Bezafibrate enhances proliferation and
differentiation of osteoblastic MC3T3-E1 cells via AMPK and eNOS
activation. Acta Pharmacol Sin. 32:591–600. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim JY, Min JY, Baek JM, Ahn SJ, Jun HY,
Yoon KH, Choi MK, Lee MS and Oh J: CTRP3 acts as a negative
regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling
in vitro and RANKL-induced calvarial bone destruction in vivo.
Bone. 79:242–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei J, Shimazu J, Makinistoglu MP, Maurizi
A, Kajimura D, Zong H, Takarada T, Iezaki T, Pessin JE, Hinoi E and
Karsenty G: Glucose uptake and Runx2 synergize to orchestrate
osteoblast differentiation and bone formation. Cell. 161:1576–1591.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhan JK, Wang YJ, Wang Y, Tang ZY, Tan P,
Huang W and Liu YS: Adiponectin attenuates the osteoblastic
differentiation of vascular smooth muscle cells through the
AMPK/mTOR pathway. Exp Cell Res. 323:352–358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhan JK, Wang YJ, Wang Y, Tang ZY, Tan P,
Huang W and Liu YS: The protective effect of GLP-1 analogue in
arterial calcification through attenuating osteoblastic
differentiation of human VSMCs. Int J Cardiol. 189:188–193. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miao XY, Gu ZY, Liu P, Hu Y, Li L, Gong
YP, Shu H, Liu Y and Li CL: The human glucagon-like peptide-1
analogue liraglutide regulates pancreatic beta-cell proliferation
and apoptosis via an AMPK/mTOR/P70S6K signaling pathway. Peptides.
39:71–79. 2013. View Article : Google Scholar
|
|
13
|
de la Croix Ndong J, Makowski AJ,
Uppuganti S, Vignaux G, Ono K, Perrien DS, Joubert S, Baglio SR,
Granchi D, Stevenson DA, et al: Corrigendum: Asfotase-α improves
bone growth, mineralization and strength in mouse models of
neurofibromatosis type-1. Nat Med. 21:4142015. View Article : Google Scholar
|
|
14
|
D'Alonzo RC, Kowalski AJ, Denhardt DT,
Nickols GA and Partridge NC: Regulation of collagenase-3 and
osteocalcin gene expression by collagen and osteopontin in
differentiating MC3T3-E1 cells. J Biol Chem. 277:24788–24798. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hughes-Fulford M and Li CF: The role of
FGF-2 and BMP-2 in regulation of gene induction, cell proliferation
and mineralization. J Orthop Surg Res. 6:82011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Owen TA, Aronow M, Shalhoub V, Barone LM,
Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB and Stein
GS: Progressive development of the rat osteoblast phenotype in
vitro: Reciprocal relationships in expression of genes associated
with osteoblast proliferation and differentiation during formation
of the bone extracellular matrix. J Cell Physiol. 143:420–430.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang L, Cheng P, Chen C, He HB, Xie GQ,
Zhou HD, Xie H, Wu XP and Luo XH: miR-93/Sp7 function loop mediates
osteoblast mineralization. J Bone Miner Res. 27:1598–1606. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paul H, Reginato AJ and Schumacher HR:
Alizarin red S staining as a screening test to detect calcium
compounds in synovial fluid. Arthritis Rheum. 26:191–200. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Singha UK, Jiang Y, Yu S, Luo M, Lu Y,
Zhang J and Xiao G: Rapamycin inhibits osteoblast proliferation and
differentiation in MC3T3-E1 cells and primary mouse bone marrow
stromal cells. J Cell Biochem. 103:434–446. 2008. View Article : Google Scholar
|
|
21
|
Ehnert S, Baur J, Schmitt A, Neumaier M,
Lucke M, Dooley S, Vester H, Wildemann B, Stöckle U and Nussler AK:
TGF-β1 as possible link between loss of bone mineral density and
chronic inflammation. PLoS One. 5:e140732010. View Article : Google Scholar
|
|
22
|
Janssens K, ten Dijke P, Janssens S and
Van Hul W: Transforming growth factor-beta1 to the bone. Endocr
Rev. 26:743–774. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Latella G, Vetuschi A, Sferra R, Speca S
and Gaudio E: Localization of ανβ6 integrin-TGF-β1/Smad3, mTOR and
PPARγ in experimental colorectal fibrosis. Eur J Histochem.
57:e402013. View Article : Google Scholar
|
|
24
|
Manzano-Moreno FJ, Medina-Huertas R,
Ramos-Torrecillas J, García-Martínez O and Ruiz C: The effect of
low-level diode laser therapy on early differentiation of
osteoblast via BMP-2/TGF-β1 and its receptors. J Craniomaxillofac
Surg. 43:1926–1932. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suzuki E, Ochiai-Shino H, Aoki H, Onodera
S, Saito A, Saito A and Azuma T: Akt activation is required for
TGF-β1-induced osteoblast differentiation of MC3T3-E1
pre-osteoblasts. PLoS One. 9:e1125662014. View Article : Google Scholar
|
|
26
|
Xiang X, Zhao J, Xu G, Li Y and Zhang W:
mTOR and the differentiation of mesenchymal stem cells. Acta
Biochim Biophys Sin (Shanghai). 43:501–510. 2011. View Article : Google Scholar
|
|
27
|
Wanachewin O, Boonmaleerat K, Pothacharoen
P, Reutrakul V and Kongtawelert P: Sesamin stimulates osteoblast
differentiation through p38 and ERK1/2 MAPK signaling pathways. BMC
Complement Altern Med. 12:712012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Scharstuhl A, Glansbeek HL, van Beuningen
HM, Vitters EL, van der Kraan PM and van den Berg WB: Inhibition of
endogenous TGF-beta during experimental osteoarthritis prevents
osteophyte formation and impairs cartilage repair. J Immunol.
169:507–514. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scharstuhl A, Vitters EL, van der Kraan PM
and van den Berg WB: Reduction of osteophyte formation and synovial
thickening by adenoviral overexpression of transforming growth
factor beta/bone morphogenetic protein inhibitors during
experimental osteoarthritis. Arthritis Rheum. 48:3442–3451. 2003.
View Article : Google Scholar : PubMed/NCBI
|
